Article
Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies.
Nutrients - 13 Jan 2023
Lawler Thomas, Warren Andersen Shaneda
Abstract excerpt
Epidemiological studies suggest that higher serum 25-hydroxyvitamin D is associated with lower risk for several cancers, including breast, prostate, colorectal, and lung cancers. To mitigate confounding, genetic instrumental variables (IVs) have been used to estimate causal associations between 25-hydroxivtamin D and cancer risk via Mendelian randomization (MR). We provide a systematic review of 31 MR studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
